ResMed, Inc. Share Price
Stocks
RMD
US7611521078
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
NYSE
01:30:02 19/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 224.99 USD | -1.50% |
|
+3.08% | -6.59% |
| Market Cap | 3.22TCr 2.81TCr 2.65TCr 2.41TCr 4.51TCr 3,08900Cr 4.53TCr 32TCr 12TCr 1,57000Cr 12TCr 12TCr 5,05300Cr | P/E 2027 * |
19.3x | P/E 2028 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.12TCr 2.72TCr 2.57TCr 2.34TCr 4.38TCr 2,99700Cr 4.39TCr 31TCr 12TCr 1,52400Cr 12TCr 11TCr 4,90300Cr | EV / Sales 2027 * |
5.37x | EV / Sales 2028 * | 4.94x |
| Free-Float |
75.13% | Yield 2027 * |
1.18% | Yield 2028 * | 1.3% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| RMD | Delayed | |
CBOE
| RMD | Real-time | |
Mexican S.E.
| RMD * | End-of-day quote | |
Boerse Muenchen
| RME | Real-time | |
Berne S.E.
| RME | End-of-day quote | |
London S.E.
| 0KW4 | Delayed | |
Deutsche Boerse AG
| RME | Delayed | |
Tradegate
| RME | Real-time | |
Börse Stuttgart
| RME | Delayed | |
Wiener Boerse
| RMD | End-of-day quote | |
Borsa Italiana
| 1RMD | End-of-day quote |
Last Transcript: ResMed, Inc.
| 1 day | -1.50% | ||
| 1 week | +3.08% | ||
| Current month | -6.29% | ||
| 1 month | +2.28% | ||
| 3 months | +19.28% | ||
| 6 months | -1.27% | ||
| Current year | -6.59% |
| 1 week | 220.94 | 234.33 | |
| 1 month | 215.8 | 242.4 | |
| Current year | 180.26 | 277.67 | |
| 1 year | 180.26 | 284.87 | |
| 3 years | 132.24 | 293.81 | |
| 5 years | 132.24 | 293.81 | |
| 10 years | 56.59 | 301.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 53 | 01/03/2013 |
Aaron Bloomer
DFI | Director of Finance/CFO | 40 | 04/05/2026 |
| Chief Tech/Sci/R&D Officer | - | 01/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 78 | 01/01/2005 |
Mick Farrell
CHM | Chairman | 53 | 25/01/2023 |
Peter Farrell
CHM | Chairman | 83 | 01/06/1989 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/09/26 | Exercice | Chief Executive Officer | 14,973 | 0.0104% | ||
| 02/09/26 | Sell | Founder | -970 | 0.0007% | ||
| 07/08/26 | Exercice | Chief Executive Officer | 14,973 | 0.0103% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.50% | +3.08% | -17.67% | +54.05% | 3.22TCr | ||
| -1.04% | +6.83% | +35.41% | +28.31% | 24TCr | ||
| -0.32% | +5.83% | +8.47% | -16.53% | 15TCr | ||
| +2.55% | +6.55% | -9.75% | +31.91% | 14TCr | ||
| -0.48% | +0.84% | -55.88% | -18.23% | 6.28TCr | ||
| +0.01% | +4.61% | +18.39% | +21.00% | 5.09TCr | ||
| -1.69% | -1.20% | -20.18% | -16.57% | 4.82TCr | ||
| +0.08% | +6.49% | +22.61% | +38.85% | 4.41TCr | ||
| -1.88% | +3.25% | +37.62% | +54.22% | 4.14TCr | ||
| -2.27% | +16.07% | +132.57% | +68.26% | 3.62TCr | ||
| Average | -0.65% | +6.18% | +15.16% | +24.53% | 8.45TCr | |
| Weighted average by Cap. | -0.31% | +6.06% | +13.82% | +19.05% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 581.12Cr 506.74Cr 478.48Cr 434.49Cr 814.07Cr 56TCr 817.47Cr 5.73TCr 2.21TCr 28TCr 2.18TCr 2.13TCr 91TCr | 619.01Cr 539.78Cr 509.67Cr 462.82Cr 867.14Cr 59TCr 870.76Cr 6.11TCr 2.36TCr 30TCr 2.33TCr 2.27TCr 97TCr |
| Net income | 164.31Cr 143.28Cr 135.29Cr 122.85Cr 230.17Cr 16TCr 231.13Cr 1.62TCr 625.36Cr 8.02TCr 617.23Cr 603.52Cr 26TCr | 178.04Cr 155.25Cr 146.59Cr 133.11Cr 249.4Cr 17TCr 250.44Cr 1.76TCr 677.6Cr 8.69TCr 668.79Cr 653.94Cr 28TCr |
| Net Debt | -95Cr -83Cr -79Cr -71Cr -133.74Cr -9.16TCr -134.3Cr -941.58Cr -363.35Cr -4.66TCr -358.63Cr -350.66Cr -15TCr | -161.27Cr -140.62Cr -132.78Cr -120.57Cr -225.91Cr -15TCr -226.85Cr -1.59TCr -613.78Cr -7.87TCr -605.79Cr -592.34Cr -25TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | $224.99 | -1.50% | 38,62,486 |
| 17/26/17 | $228.42 | +0.07% | 10,85,530 |
| 16/26/16 | $228.25 | -0.52% | 10,66,869 |
| 15/26/15 | $229.44 | +2.89% | 16,41,047 |
| 14/26/14 | $222.99 | +2.16% | 9,89,010 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMD Stock
Select your edition
All financial news and data tailored to specific country editions

















